Compounds > ribavirin
Page last updated: 2024-08-16

ribavirin and Ebola Hemorrhagic Fever

ribavirin has been researched along with Ebola Hemorrhagic Fever in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (66.67)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
Chen, Q; Smith, A1
Barron, S; Barrot, L; Carbonnelle, C; de Lamballerie, X; Duthey, A; Guedj, J; Jacquot, F; Lacarelle, B; Madelain, V; Mentré, F; Mundweiler, S; Raoul, H; Solas, C; Thomas, D; Vallvé, A1
Aliota, MT; Bonnac, LF; Geraghty, RJ1
Li, T; Sheng, M; Xu, J; Yu, X; Zhong, Y1
Alfson, KJ; Carrion, R; Griffiths, A; Worwa, G1
Bailey, KW; Bray, M; Dagley, A; Downs, B; Furuta, Y; Gowen, BB; Jung, KH; Sefing, EJ; Smee, DF; Van Wettere, AJ; Wandersee, L; Westover, JB1

Reviews

1 review(s) available for ribavirin and Ebola Hemorrhagic Fever

ArticleYear
Broad-Spectrum Antiviral Strategies and Nucleoside Analogues.
    Viruses, 2021, 04-13, Volume: 13, Issue:4

    Topics: Adenosine Monophosphate; Alanine; Amides; Animals; Antiviral Agents; COVID-19 Drug Treatment; Hemorrhagic Fever, Ebola; Humans; Middle East Respiratory Syndrome Coronavirus; Mutagenesis; Nucleosides; Pyrazines; Ribavirin; SARS-CoV-2; Virus Replication; Zika Virus; Zika Virus Infection

2021

Other Studies

5 other study(ies) available for ribavirin and Ebola Hemorrhagic Fever

ArticleYear
l-like 3-deazaneplanocin analogues: Synthesis and antiviral properties.
    Bioorganic & medicinal chemistry letters, 2019, 10-01, Volume: 29, Issue:19

    Topics: Adenosine; Antiviral Agents; Arenaviridae; Arenaviridae Infections; Ebolavirus; Hemorrhagic Fever, Ebola; Humans; Molecular Structure

2019
Ribavirin does not potentiate favipiravir antiviral activity against Ebola virus in non-human primates.
    Antiviral research, 2020, Volume: 177

    Topics: Amides; Animals; Antiviral Agents; Disease Models, Animal; Ebolavirus; Female; Hemorrhagic Fever, Ebola; Macaca fascicularis; Pyrazines; Ribavirin; Viral Load; Virus Replication

2020
Potential clinical treatment for Ebola pandemic.
    Science China. Life sciences, 2014, Volume: 57, Issue:10

    Topics: Africa, Western; Animals; Disease Outbreaks; Hemorrhagic Fever, Ebola; Humans; Mice; Pandemics; Ribavirin

2014
Determination and Therapeutic Exploitation of Ebola Virus Spontaneous Mutation Frequency.
    Journal of virology, 2015, Dec-16, Volume: 90, Issue:5

    Topics: Animals; Antiviral Agents; Disease Models, Animal; Ebolavirus; Female; Genes, Reporter; Genetic Variation; Green Fluorescent Proteins; Hemorrhagic Fever, Ebola; High-Throughput Nucleotide Sequencing; Humans; Inhibitory Concentration 50; Macaca fascicularis; Male; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mutation Rate; Ribavirin; RNA, Viral; Sequence Analysis, DNA; Survival Analysis; Treatment Outcome

2015
Low-dose ribavirin potentiates the antiviral activity of favipiravir against hemorrhagic fever viruses.
    Antiviral research, 2016, Volume: 126

    Topics: Amides; Animals; Antiviral Agents; Arenavirus; Chlorocebus aethiops; Cricetinae; Dengue Virus; Disease Models, Animal; Drug Synergism; Female; Guinea Pigs; Hemorrhagic Fever Virus, Crimean-Congo; Hemorrhagic Fever, American; Hemorrhagic Fever, Ebola; Hemorrhagic Fevers, Viral; Junin virus; Male; Mesocricetus; Mice; Orthohantavirus; Pyrazines; Ribavirin; RNA Viruses; Vero Cells

2016